Reported about 10 hours ago
DexCom, Inc., a leading medical device company known for its continuous glucose monitoring systems, is set to report its fiscal 2025 Q2 earnings on July 30. Analysts predict a profit of $0.45 per share, a growth from last year’s $0.43, with expectations for a full year EPS rise to $2.03. Despite a 25.2% dip in share value over the past year, analysts maintain a strong buy rating, indicating a potential upside of 20.2% from current levels.
Source: YAHOO